Keywords: tokyo, pharma, stocks, week, feb, witnessed, extended
Tokyo pharma stocks - week to Feb 9
Article | 16 February 2004
Tokyo witnessed an extended correction phase in the week ended February 9. The Nikkei 225 dropped 3.5% to close at 10,402.61, with day-to-day declines ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
